Table 2.
Matched pre-operative demographic, clinical, and echocardiographic parameters
| Perimount, n=102 | Perceval, n=102 | P-value | |||
|---|---|---|---|---|---|
| Age / years | 74.0 ± 6.4 | 73.7 ± 6.7 | 0.733 | ||
| % Female | 33.3% (34) | 39.2% (40) | 0.382 | ||
| BMI / kgm-2 | 27.2 (24; 30) | 28.6 (25; 32) | 0.163 | ||
| EuroSCORE II | 1.96 (1.3; 3.3) | 1.95 (1.5; 3.0) | 0.937 | ||
| Diabetes | 26.5% (27) | 24.5% (25) | 0.748 | ||
| Previous or current smoker | 50% (51) | 55.9% (57) | 0.400 | ||
| Previous PCI | 12.7% (13) | 6.9% (7) | 0.158 | ||
| Hypertension | 78.4% (80) | 72.5% (74) | 0.329 | ||
| Perimount | n | Perceval | n | P-value | |
| LVEF | 60 (55; 65) | 100 | 59.5 (55; 65) | 102 | 0.135 |
| PG / mmHg | 72.3 (62; 89) | 96 | 76 (63; 95) | 97 | 0.736 |
| MG / mmHg | 41 (35; 52) | 94 | 45 (36; 57) | 96 | 0.393 |
| iEOA / cm2 | 0.42 (0.37; 0.52) | 75 | 0.44 (0.36; 0.51) | 84 | 0.730 |
| Vmax aortic valve / ms-1 | 4.3 (4.0; 4.7) | 88 | 4.4 (3.9; 4.9) | 94 | 0.762 |
| Mixed AS + AR / % (n) | 10.8% (11) | 102 | 12.7% (13) | 102 | 0.664 |
| LVOT / cm | 2.3 (2.2; 2.5) | 86 | 2.3 (2.1; 2.3) | 79 | 0.311 |
| LVDd / cm | 4.9 (4.2; 5.3) | 87 | 5.1 (4.7; 5.4) | 86 | 0.280 |
| LVSd / cm | 3.1 ± 0.65 | 84 | 3.1 ± 0.67 | 86 | 0.734 |
| IVSd / cm | 1.4 (1.3; 1.5) | 87 | 1.3 (1.0; 1.4) | 85 | 0.300 |
| LVPWd / cm | 1.14 ± 0.28 | 87 | 1.18 ± 0.23 | 86 | 0.292 |
Values are mean ± SD or median (LQ to UQ), and % (n)
BMI: body mass index, PCI: percutaneous coronary intervention, LVEF: left ventricular ejection fraction, PG: peak gradient, MG: mean gradient, iEOA: indexed effective orifice area, Vmax: maximum velocity across aortic valve, LVDd: left ventricular diastolic dimension, LVSd: left ventricular systolic dimension, IVSd: interventricular septal diastolic dimension, LVOT: left ventricular outflow tract dimension, LVPWd: left ventricular posterior wall dimension